Back
Molina Healthcare 10K Form
Sell
49
MOH
Molina Healthcare
Last Price:
333.22
Seasonality Move:
3.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | MOH/Molina Healthcare Quarterly |
2023-10-26 | 10Q | MOH/Molina Healthcare Quarterly |
2023-07-27 | 10Q | MOH/Molina Healthcare Quarterly |
2023-04-27 | 10Q | MOH/Molina Healthcare Quarterly |
2022-10-27 | 10Q | MOH/Molina Healthcare Quarterly |
2022-07-28 | 10Q | MOH/Molina Healthcare Quarterly |
Receive MOH News And Ratings
See the #1 stock for the next 7 days that we like better than MOH
MOH Financial Statistics
Sales & Book Value
Annual Sales: | $34.07B |
---|---|
Cash Flow: | $838M |
Price / Cash Flow: | 205.97 |
Annual Sales: | $83.68 |
Price / Book: | 4 |
Profitability
EPS (TTM): | 19.69000 |
---|---|
Net Income (TTM): | $1.14B |
Gross Margin: | $4.33B |
Return on Equity: | 25.77% |
Return on Assets: | 7.51% |
Molina Healthcare Earnings Forecast
Key Molina Healthcare Financial Ratios
- The Gross Profit Margin over the past 23 years for MOH is 12.72%.
- The Selling, General & Administrative Expenses for MOH have been equal to 7.23% of Gross Profit Margin.
- The Interest Expense is 9.99% of Operating Income.
- The Net Earning history of MOH is 3.20% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 17 years.
Molina Healthcare Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care Providers & Services |
Sector: | Health Care |
Current Symbol: | MOH |
CUSIP: | 60855R |
Website: | molinahealthcare.com |
Debt
Debt-to-Equity Ratio: | 0.49 |
---|---|
Current Ratio: | 1.55 |
Quick Ratio: | 1.5 |
Price-to-Earnings
Trailing P/E Ratio: | 17.76 |
---|---|
Forward P/E Ratio: | 12.73 |
MOH Technical Analysis vs Fundamental Analysis
Sell
49
Molina Healthcare (MOH)
is a Sell
Is Molina Healthcare a Buy or a Sell?
-
Molina Healthcare stock is rated a Sell
The current Molina Healthcare [MOH] share price is $333.39. The Score for MOH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.